WO2007039124A2 - Compositions comprising colostrum and hyaluronic acid for the treatment of vaginal dryness - Google Patents
Compositions comprising colostrum and hyaluronic acid for the treatment of vaginal dryness Download PDFInfo
- Publication number
- WO2007039124A2 WO2007039124A2 PCT/EP2006/009183 EP2006009183W WO2007039124A2 WO 2007039124 A2 WO2007039124 A2 WO 2007039124A2 EP 2006009183 W EP2006009183 W EP 2006009183W WO 2007039124 A2 WO2007039124 A2 WO 2007039124A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- vaginal
- colostrum
- hyaluronic acid
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
Definitions
- the present invention relates to vaginal compositions comprising colostrum and hyaluronic acid, useful for the treatment of vaginal dryness in menopause.
- Vaginal dryness is one of the consequences of the decrease in estrogen levels in menopause.
- the fall in circulating estrogen level involves in fact the thinning of the vaginal walls, with reduction of elasticity and decrease in the natural secretion and lubrication, which makes sexual intercourse difficult and painful.
- Vaginal dryness is usually treated with the replacement therapy comprising estrogens, which however involves well known side effects (slight increase in the number of breast tumours, slight increase in stroke cases, risk of "stimulation" of endometrious with possible “hyperplasia”, increase in the risk of thrombotic phenomena).
- vaginal topical compositions comprising colostrum exert a beneficial action on vaginal epithelium, increasing its elasticity and promoting mucosal secretion.
- the present invention relates to fluid compositions in the form of vaginal creams, gel, solutions, ovules, suppositories, capsules or washes containing colostrum and hyaluronic acid, useful for the treatment of vaginal dryness in menopause.
- the present invention also relates to the use of colostrum and hyaluronic acid for the treatment of vaginal dryness associated to postmenopausal syndrome.
- colostrum can derive from any mammal, preferably of equine, bovine, ovine origin, and it will be present in the compositions of the invention in percentages ranging from 5 to 0%.
- hyaluronic acid will be present in the compositions of the invention in percentages ranging from 0.1 to 2%.
- the compositions of the present invention will also contain soy isoflavones. Soy isoflavones are phytoestrogens that have been used for a long time in replacement therapy.
- soy isoflavones can be selected from genistein, daidzein, glycitein and their glycosides genistin, daidzin and glycitin, and they will be present in percentages ranging preferably from 0.01 to 5% by weight.
- compositions of the present invention will also contain vegetable extracts from plants which exert a complementary or anyway useful activity for the purposes of the invention, for example estrogenic, anti-inflammatory, antifungal, antibacterial, re-epithelizing, hydrating, decongesting, microcirculation-improving, protective, antioxidant, refreshing activities and the like.
- Examples of said plants are coconut palm ⁇ Elaeis guineensis), aloe ⁇ Aloe barbadensis), cypress (Cupressus saffirvirens), maca (Lepidium meyeni ⁇ ), minth ⁇ Mentha piperita), thyme ⁇ Thymus vulgaris), vervain ⁇ Lippia citriodora), oreganon ⁇ Origanum vulgare), and plants of the Citrus genus.
- compositions of the present invention proved to exert a synergetic activity: in fact they exert a surprisingly higher action than that obtained from the sum of the activity of the single active components.
- compositions of the present invention will be formulated in the form of vaginal gel, creams, solutions, ovules, suppositories, capsules and washes, using techniques and conventional excipients well-known in the pharmaceutical technique, such as diluents, disintegrants, moisturizers and lubricants.
- a preferred formulation is that in cream.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to vaginal compositions containing colostrum and hyaluronic acid, more particularly fluid compositions in the form of vaginal creams, gel, solutions, ovules, suppositories, capsules or washes, useful for the treatment of vaginal dryness in menopause.
Description
COMPOSITIONS COMPRISING COLOSTRUM AND HYALURONIC ACID FOR THE TREATMENT OF VAGINAL DRYNESS
Summary of the invention
The present invention relates to vaginal compositions comprising colostrum and hyaluronic acid, useful for the treatment of vaginal dryness in menopause. Technical background
Vaginal dryness is one of the consequences of the decrease in estrogen levels in menopause. The fall in circulating estrogen level involves in fact the thinning of the vaginal walls, with reduction of elasticity and decrease in the natural secretion and lubrication, which makes sexual intercourse difficult and painful. Vaginal dryness is usually treated with the replacement therapy comprising estrogens, which however involves well known side effects (slight increase in the number of breast tumours, slight increase in stroke cases, risk of "stimulation" of endometrious with possible "hyperplasia", increase in the risk of thrombotic phenomena). It has now been found that vaginal topical compositions comprising colostrum exert a beneficial action on vaginal epithelium, increasing its elasticity and promoting mucosal secretion.
Disclosure of the invention
Therefore, the present invention relates to fluid compositions in the form of vaginal creams, gel, solutions, ovules, suppositories, capsules or washes containing colostrum and hyaluronic acid, useful for the treatment of vaginal dryness in menopause.
The present invention also relates to the use of colostrum and hyaluronic acid for the treatment of vaginal dryness associated to postmenopausal syndrome. According to the present invention, colostrum can derive from any
mammal, preferably of equine, bovine, ovine origin, and it will be present in the compositions of the invention in percentages ranging from 5 to 0%. According to the present invention, hyaluronic acid will be present in the compositions of the invention in percentages ranging from 0.1 to 2%. According to a preferred aspect of the present invention, the compositions of the present invention will also contain soy isoflavones. Soy isoflavones are phytoestrogens that have been used for a long time in replacement therapy. It is in fact known that Asian women, thanks to a diet rich in phytoestrogens, have markedly fewer postmenopausal symptoms than Western women. According to the present invention, soy isoflavones can be selected from genistein, daidzein, glycitein and their glycosides genistin, daidzin and glycitin, and they will be present in percentages ranging preferably from 0.01 to 5% by weight.
According to a preferred aspect, the compositions of the present invention will also contain vegetable extracts from plants which exert a complementary or anyway useful activity for the purposes of the invention, for example estrogenic, anti-inflammatory, antifungal, antibacterial, re-epithelizing, hydrating, decongesting, microcirculation-improving, protective, antioxidant, refreshing activities and the like. Examples of said plants are coconut palm {Elaeis guineensis), aloe {Aloe barbadensis), cypress (Cupressus semprevirens), maca (Lepidium meyeniϊ), minth {Mentha piperita), thyme {Thymus vulgaris), vervain {Lippia citriodora), oreganon {Origanum vulgare), and plants of the Citrus genus.
The compositions of the present invention proved to exert a synergetic activity: in fact they exert a surprisingly higher action than that obtained from the sum of the activity of the single active components.
The compositions of the present invention will be formulated in the form of vaginal gel, creams, solutions, ovules, suppositories, capsules and
washes, using techniques and conventional excipients well-known in the pharmaceutical technique, such as diluents, disintegrants, moisturizers and lubricants. According to the present invention, a preferred formulation is that in cream.
An example of formulation according to the invention is reported below:
Example - Vaginal cream
Claims
1. Vaginal compositions containing colostrum and hyaluronic acid for the treatment of vaginal dryness in menopause.
2. Compositions as claimed in claim 1, in which colostrum derives from any mammal, preferably of equine, bovine, ovine origin.
3. Compositions as claimed in claim 1 e 2, containing colostrum in percentages ranging from 5 to 30%.
4. Compositions as claimed in claim 1 e 2, containing hyaluronic acid in percentages ranging from 0.1 to 2%.
5. Compositions according to the above claims, further containing soy isoflavones.
6. Compositions according to the above claims, further containing vegetable extracts from plants selected from the group consisting of Elaeis guineensis, Aloe barbadensis, Cupressus semprevirens, Mentha piperita, Thymus vulgaris, Lippia citriodora, Origanum vulgare, and plants of the Citrus genus.
7. Compositions as claimed in any one of the above claims, in the form of vaginal creams, gel, solutions, ovules, suppositories, capsules or washes.
8. Compositions as claimed in claim 6, in the form of creams.
9. The use of colostrum for the preparation of compositions vaginal for the treatment of vaginal dryness in menopause.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06805796A EP1940517A2 (en) | 2005-09-23 | 2006-09-21 | Compositions comprising colostrum and hyaluronic acid for the treatment of vaginal dryness |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT001777A ITMI20051777A1 (en) | 2005-09-23 | 2005-09-23 | COLOSSUS-BASED COMPOSITIONS FOR VAGINAL DRYING TREATMENT |
ITMI2005A001777 | 2005-09-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007039124A2 true WO2007039124A2 (en) | 2007-04-12 |
WO2007039124A3 WO2007039124A3 (en) | 2007-06-28 |
Family
ID=37890564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/009183 WO2007039124A2 (en) | 2005-09-23 | 2006-09-21 | Compositions comprising colostrum and hyaluronic acid for the treatment of vaginal dryness |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1940517A2 (en) |
IT (1) | ITMI20051777A1 (en) |
WO (1) | WO2007039124A2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010028652A1 (en) | 2008-09-12 | 2010-03-18 | Nanoko A/S | Colostrum composition |
ITMI20091628A1 (en) * | 2009-09-24 | 2011-03-25 | You Biomedical Res Srl | COMPOSITIONS FOR THE TREATMENT OF VAGINAL DRYNESS AND RECURRENT VAGINAL INFECTIONS |
CN102239922A (en) * | 2010-05-13 | 2011-11-16 | 江苏星驰生物科技有限公司 | Colostrum formula powder |
ITRM20100419A1 (en) * | 2010-07-28 | 2012-01-29 | Galsor S R L | PHARMACEUTICAL COMPOSITION BASED ON ONE OR MORE FRACTIONS OF HYALURONIC ACID OR ITS SALTS ASSOCIATED WITH AN INHIBITOR OF IALURONIDASI AND ITS USES IN MEDICAL FIELD. |
ITMI20102260A1 (en) * | 2010-12-09 | 2012-06-10 | Bionest Ltd | MULTIPURPOSE GEL AGAINST THE VAGINAL DRYNESS WITH A DIRECT AND DELAYED EFFECT |
ITMI20112438A1 (en) * | 2011-12-30 | 2013-07-01 | Bionest Ltd | INJECTABLE FORMULATIONS OF CYTOKINES, GROWTH FACTORS, CHEMOTACTIC FACTORS, STAMINAL STIMULATION FATORS AND RNA FOR DERMA REGENERATION |
WO2019213473A1 (en) * | 2018-05-04 | 2019-11-07 | The Procter & Gamble Company | Compositions and methods for treating vaginal dryness |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6251436B1 (en) * | 1995-09-29 | 2001-06-26 | L.A.M. Pharmaceutical Corporation | Drug preparations for treating sexual dysfunction |
EP1444984A1 (en) * | 2003-02-06 | 2004-08-11 | B.S.D. BIO SCIENCE DEVELOPMENT SNC Di OMINI C. & ZUCCARI G. | Topical pharmaceutical compositions containing natural active constituents suitable for the prevention and treatment of mucosal inflammation processes |
WO2004089278A2 (en) * | 2003-04-09 | 2004-10-21 | Dolhay Klinika Egészségügyi Kft. | Sexual hygienic composition |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5953425A (en) * | 1982-09-22 | 1984-03-28 | Meiji Milk Prod Co Ltd | Vaginal lubricant |
CN1175401A (en) * | 1996-09-03 | 1998-03-11 | 深圳市龙岗区新业有限公司 | SOD essence for skin care and special conditioning liquid thereof |
-
2005
- 2005-09-23 IT IT001777A patent/ITMI20051777A1/en unknown
-
2006
- 2006-09-21 EP EP06805796A patent/EP1940517A2/en not_active Withdrawn
- 2006-09-21 WO PCT/EP2006/009183 patent/WO2007039124A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6251436B1 (en) * | 1995-09-29 | 2001-06-26 | L.A.M. Pharmaceutical Corporation | Drug preparations for treating sexual dysfunction |
EP1444984A1 (en) * | 2003-02-06 | 2004-08-11 | B.S.D. BIO SCIENCE DEVELOPMENT SNC Di OMINI C. & ZUCCARI G. | Topical pharmaceutical compositions containing natural active constituents suitable for the prevention and treatment of mucosal inflammation processes |
WO2004089278A2 (en) * | 2003-04-09 | 2004-10-21 | Dolhay Klinika Egészségügyi Kft. | Sexual hygienic composition |
Non-Patent Citations (5)
Title |
---|
"Cryosplin: wound healing remedy" EPODOC, 2004, XP002401523 * |
"ORLANE" PROMT, 1991, XP002403656 * |
BECLERE C ET AL: "[Colostrum sterols in the treatment of post-menopausal disorders.]" SEMAINE MÉDICALE PROFESSIONELLE ET MÉDICO-SOCIALE 14 OCT 1957, vol. 33, no. 37, 14 October 1957 (1957-10-14), pages 1430-1433, XP001249074 * |
DATABASE WPI Week 198419 Derwent Publications Ltd., London, GB; AN 1984-116620 XP002430224 & JP 59 053425 A (MEIJI MILK PROD CO LTD) 28 March 1984 (1984-03-28) * |
DATABASE WPI Week 200211 Derwent Publications Ltd., London, GB; AN 2002-075790 XP002430223 & CN 1 175 401 A (XINYE CO LTD LONGGANG DISTRICT SHENZHEN) 11 March 1998 (1998-03-11) * |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010028652A1 (en) | 2008-09-12 | 2010-03-18 | Nanoko A/S | Colostrum composition |
US8637075B2 (en) | 2008-09-12 | 2014-01-28 | Pharma Gp Aps | Colostrum composition |
ITMI20091628A1 (en) * | 2009-09-24 | 2011-03-25 | You Biomedical Res Srl | COMPOSITIONS FOR THE TREATMENT OF VAGINAL DRYNESS AND RECURRENT VAGINAL INFECTIONS |
CN102239922A (en) * | 2010-05-13 | 2011-11-16 | 江苏星驰生物科技有限公司 | Colostrum formula powder |
ITRM20100419A1 (en) * | 2010-07-28 | 2012-01-29 | Galsor S R L | PHARMACEUTICAL COMPOSITION BASED ON ONE OR MORE FRACTIONS OF HYALURONIC ACID OR ITS SALTS ASSOCIATED WITH AN INHIBITOR OF IALURONIDASI AND ITS USES IN MEDICAL FIELD. |
JP2013544858A (en) * | 2010-12-09 | 2013-12-19 | ツァンボン ソシエタ ペル アチオニ | Versatile gel for vaginal dryness with direct and delayed effects |
CN103338778A (en) * | 2010-12-09 | 2013-10-02 | 赞邦股份公司 | Multipurpose gel for vaginal dryness with direct and delayed effect |
WO2012076409A1 (en) * | 2010-12-09 | 2012-06-14 | Zambon S.P.A. | Multipurpose gel for vaginal dryness with direct and delayed effect |
ITMI20102260A1 (en) * | 2010-12-09 | 2012-06-10 | Bionest Ltd | MULTIPURPOSE GEL AGAINST THE VAGINAL DRYNESS WITH A DIRECT AND DELAYED EFFECT |
US9248151B2 (en) | 2010-12-09 | 2016-02-02 | Zambon S.P.A. | Multipurpose gel for vaginal dryness with direct and delayed effect |
AU2011340757B2 (en) * | 2010-12-09 | 2016-10-27 | Zambon S.P.A. | Multipurpose gel for vaginal dryness with direct and delayed effect |
EA026198B1 (en) * | 2010-12-09 | 2017-03-31 | Замбон С.П.А. | Multipurpose gel for vaginal dryness with direct and delayed effect |
ITMI20112438A1 (en) * | 2011-12-30 | 2013-07-01 | Bionest Ltd | INJECTABLE FORMULATIONS OF CYTOKINES, GROWTH FACTORS, CHEMOTACTIC FACTORS, STAMINAL STIMULATION FATORS AND RNA FOR DERMA REGENERATION |
WO2019213473A1 (en) * | 2018-05-04 | 2019-11-07 | The Procter & Gamble Company | Compositions and methods for treating vaginal dryness |
CN112088010A (en) * | 2018-05-04 | 2020-12-15 | 宝洁公司 | Compositions and methods for treating vaginal dryness |
US11633452B2 (en) | 2018-05-04 | 2023-04-25 | The Procter & Gamble Company | Compositions and methods for treating vaginal dryness |
Also Published As
Publication number | Publication date |
---|---|
EP1940517A2 (en) | 2008-07-09 |
WO2007039124A3 (en) | 2007-06-28 |
ITMI20051777A1 (en) | 2007-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1940517A2 (en) | Compositions comprising colostrum and hyaluronic acid for the treatment of vaginal dryness | |
CA2951433C (en) | Compositions and methods for managing or improving bone disorders, cartilage disorders, or both | |
Abdi et al. | Hops for menopausal vasomotor symptoms: Mechanisms of action | |
EP1503778B1 (en) | Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent | |
Dong et al. | Phytochemicals and biological studies of plants in genus Hedysarum | |
JP2012511547A (en) | Isoflavone composition | |
CN102423291A (en) | Traditional Chinese medicine antibiotic skincare hand cleanser and preparation method thereof | |
US20230201295A1 (en) | Compositions and Methods for Managing or Improving Bone Disorders, Joint Disorders, Cartilage Disorders, or a Combination Thereof | |
WO2009003631A1 (en) | Combinations of vasoactive substances with estrogens and their use in the treatment of female sexual dysfunctions | |
CN101417068B (en) | Traditional Chinese medicine bacteriostatic lotion and preparation method thereof | |
F Kashan et al. | Effect of Verbascum thapsus ethanol extract on induction of apoptosis in Trichomonas vaginalis in vitro | |
CN111700958A (en) | Gel bacteriostatic preparation | |
CN102552989A (en) | Multifunctional personal lubricant | |
EP1348439B1 (en) | Compositions for vaginal use | |
Rauf et al. | Pharmacological investigation of genus Pistacia | |
ES2134301T3 (en) | PHARMACEUTICAL COMPOSITION FOR THE PROPHYLAXIS AND TREATMENT OF EARLY EJACULATION. | |
BR0209629A (en) | Use of extracts and preparations from iridaceae and tectorigenin as an organoselective drug for the treatment of sex hormone-related disorders in the urogenital tract | |
CN107811894A (en) | A kind of cold cream with olive oil and preparation method thereof | |
CN106176525B (en) | A kind of Chinese herbal medicine shower cream | |
US20120083747A1 (en) | Vaginal renewal complex and applicator | |
US7563464B1 (en) | Treatment of mucosal membranes utilizing phytoestrogen | |
WO2012048446A8 (en) | New use of chemical ingredients in cynomorium as phytoestrogen | |
KR20170083493A (en) | Composition for relieving menopausal symptom | |
CN108815274A (en) | Clean maintenance bacteriostatic gel of woman and its preparation method and application | |
US11419828B2 (en) | Hair care terpinen 4-ol (T4O) composition for the treatment of demodex mites on scalp |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006805796 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2006805796 Country of ref document: EP |